APPLICATION OF TREAT TO TARGET AND IMPACT OF SUSTAINED LOW DISEASE ACTIVITY OR REMISSION ON FUNCTION IN PSORIATIC ARTHRITIS PATIENTS

被引：0
|
作者：
Rahman, Proton [1 ]
Arendse, Reagan [2 ]
Baer, Philip
Zummer, Michael [3 ]
Rampakakis, Emmanouil [4 ]
Lehman, Allen J. [5 ]
Rachich, Meagan [5 ]
Nantel, Francois [5 ]
Asin-Milan, Odalis [5 ]
机构：
[1] Mem Univ, St John, NF, Canada
[2] Univ Saskatchewan, Saskatoon, SK, Canada
[3] Univ Montreal, Montreal, PQ, Canada
[4] JSS Med Res, Montreal, PQ, Canada
[5] Janssen Inc, Toronto, ON, Canada
来源：
INTERNAL MEDICINE JOURNAL | 2020年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARA-23
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [41] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT IN FUNCTION, QUALITY OF LIFE AND FATIGUE OVER TWO YEARS IN PATIENTS WHO ACHIEVED DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS REMISSION
    McInnes, Lain
    Smolen, Josef S.
    Gossec, Laura
    Strand, vibeke
    Pricop, Luminita
    Fox, Todd
    Jugl, Steffen
    Gaillez, Corine
    RHEUMATOLOGY, 2018, 57
  • [42] TREAT TO TARGET EARLY RHEUMATOID ARTHRITIS CLINIC: HIGH RATES OF REMISSION AND LOW DISEASE ACTIVITY ON TREATMENT WITH CONVENTIONAL DISEASE MODIFYING DRUGS
    Semenova, O.
    Thompson, H.
    Kallankara, S.
    Olabambo, O.
    Patel, Y.
    Baguley, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 205 - 206
  • [43] Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol
    Sundlisaeter, Nina Paulshus
    Olsen, Inge C.
    Aga, Anna-Birgitte
    Hammer, Hilde B.
    Uhlig, Till
    van der Heijde, Desiree
    Kvien, Tore K.
    Lillegraven, Siri
    Haavardsholm, Espen A.
    RHEUMATOLOGY, 2018, 57 (11) : 2022 - 2031
  • [44] OBESITY AND LOWER LIKELIHOOD OF ACHIEVING MINIMAL DISEASE ACTIVITY AND REMISSION IN PSORIATIC ARTHRITIS PATIENTS
    Vallejo-Yague, E.
    Burkard, T.
    Moeller, B.
    Burden, A. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 860 - 860
  • [45] SECUKINUMAB PROVIDES SUSTAINED REMISSION AND LOW DISEASE ACTIVITY RELATED TO DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS (DAPSA): 2 YEAR RESULTS FROM THE FUTURE 2 STUDY
    Smolen, J. S.
    McInnes, I. B.
    Kvien, T. K.
    Pricop, L.
    Fox, T.
    Rasouliyan, L.
    Jugl, S.
    Gaillez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1323 - 1324
  • [46] Implementing Psoriatic Arthritis Disease Activity Score-guided treat-to-target in psoriatic arthritis routine clinical practice: (im)possible?
    Mulder, Michelle L. M.
    den Broeder, Alfons A.
    van Ginneken, Berbke T. J.
    Mahler, Elien A. M.
    van den Hoogen, Frank H. J.
    Vriezekolk, Johanna E.
    Wenink, Mark H.
    RHEUMATOLOGY, 2019, 58 (12) : 2330 - 2331
  • [47] Very low disease activity, DAPSA remission, and impact of disease in a Spanish population with psoriatic arthritis (vol 46, pg 710, 2019)
    Queiro, R.
    Canete, J. D.
    Montilla, C.
    Abad, M. A.
    Montoro, M.
    Gomez, S.
    Cabez, A.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (09) : 1252 - 1252
  • [48] Patient-Reported Outcomes Differentiate Between Remission and Low Disease Activity in Psoriatic Arthritis
    Yedimenko, Juliette
    Walsh, Jessica
    Ogdie, Alexis
    Jin, Yuxuan
    Reddy, Soumya
    Scher, Jose
    Husni, M. Elaine
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [49] PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH APREMILAST
    Mease, Philip J.
    Behrens, Frank
    Gladman, Dafna D.
    Kavanaugh, Arthur
    Brunori, Michele
    Teng, Lichen
    Guerette, Benoit
    Queiro, Ruben
    Ogdie, Alexis
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 916 - 917
  • [50] Treating Psoriatic Arthritis to Target: Defining the Psoriatic Arthritis Disease Activity Score That Reflects a State of Minimal Disease Activity
    Perruccio, Anthony, V
    Got, Matthew
    Li, Suzanne
    Ye, Yang
    Gladman, Dafna D.
    Chandran, Vinod
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (03) : 362 - 368
12345